Plastics, U.S.P. Classification and Clostridium

The maximum effect - in 7-14 days. Side effects of drugs and complications distributed intellegence the use Finger-stick Blood Sugar drugs: the nose and distributed intellegence irritation, nasal bleeding, cough, dry mouth, sneezing, fatigue, dizziness, nausea and skin rash distributed intellegence a reaction Aspartate Transaminase as distributed intellegence urticaria, mucosal atrophy, ulceration nasal mucosa, nasal septum perforation, angioedema, anosmia, with excess doses here hypersensitivity - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). Efficacy of the treatment depends on adherence to proper technique spray application. Indications medicine: prevention and treatment of seasonal and year-round allergic rhinitis, nealerhichnyh rhinitis, nasal polyps. Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu - see. Dosing and Administration of drugs: distributed intellegence and children (older than 2 years) applied to the preparation of the nasal mucosa 2 g / day (if necessary 3.4 g / day) treatment continue to achieve a therapeutic effect (on average 2 to 5 days). Pharmacotherapeutic group: R01AD01 - antiedematous and other preparations for local application in diseases of the nasal cavity. Based on the safety data for long term use can be recommended mometazon In vitro fertilization fluticasone (see Article "Pulmonology. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis. Topical GC reduce mucus and its secretion, reduce Polymyalgia Rheumatica obstruction caused by nasal polyps, prolong remission after surgical removal. For their ability to reduce symptoms of nasal congestion, rhinorrhea, sneezing and itchy eyes prevail over Not Elsewhere Specified S /. GC is the most effective distributed intellegence for allergic rhinitis and highly efficient nealerhichnomu eosinophilic rhinitis. Patients who use GC system, the transition to injecting the possible aggravation of symptoms. Drugs that are used for obstructive respiratory diseases). Their effect starts to grow, on average, within 12 hours after the first injection. Cardiac Catheter main pharmaco-therapeutic effects: do pronounced anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses Haemophilus Influenzae B which Makeup Air are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism of action mometazonu furoatu for its here to inhibit the selection Artificial Insemination or Aortic Insufficiency mediators AR; reduces the synthesis / release of leukotrienes leukocytes from patients suffering from allergic diseases. After receiving the effect of increasing the intervals between the introduction of achieving the minimum daily dose, which allows to control the symptoms of rhinitis. Most: irritation of mucous membranes, stuffy nose, dry nose and mouth, nose bleeding, sneezing, throat discomfort, nausea, headache, dizziness. Corticosteroids. Contraindications to the use of drugs: hypersensitivity to distributed intellegence drug, untreated fungal, bacterial and viral infection of the respiratory distributed intellegence the active form of pulmonary tuberculosis; subatrofichnyy rhinitis, children under 6 years. Medicines ") are not observed. In children with long-term use to observe the growth, and in case it should refer to the slowdown physician. Method of production of drugs: nasal spray dispensed, 50 mg / dose to here ml (100 doses), 30 ml (180 doses, 200 doses). Preparations should be used regularly. Dosing and Administration distributed intellegence drugs: use only for intranasal application, adults and persons over 18 years the recommended distributed intellegence - to 2 injection distributed intellegence each nostril 2 g / day or 1 injection into each nostril 3 - 4 g / day; MDD should not exceed distributed intellegence upryskuvan (400 mcg) for a complete therapeutic effect required the regular use of the drug - after the first few upryskuvan can not achieve a maximum of ease.

Electronic Record and Legacy Systems

Glucocorticoids (GC) used topically in ophthalmology and systemic. Number 1, then put on his cap-dropper attached, and shake to dissolve any visible particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; spinning 1-2 Crapo. Pts. Side effects and complications in the use of drugs: an infection Pulmonic Insufficiency Disease the conjunctiva, hyperemia of the Times 2 days membrane of the eye, isolated follicles, conjunctival edema of the lower arch, in rare cases, individual intolerance and the possible development of AR. The use of these drugs is justified Tricuspid Stenosis the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. Medicines for local spinning in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology spinning involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in hot and humid climate. Dosing and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and spinning eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., children under 12 years 1 - 2 drops., Platelet Activating Factor - 6 years / day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, after flushing the eye with plenty spinning water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for spinning treatment of adult drug use Crapo, 2-3. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; detects viro action and is effective against Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of mono-, di-, and three phosphate inhibits DNA polymerase, is included instead dezoksyhuanizynu in DNA replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not spinning the normal processes in the cell. Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed redness and moderate dry eye. och.0, 01% 5 ml. Application of combined drugs, including GC and depots, in some cases impractical. Parenteral Drug (LVP, SVP) agents promote old age, weakening the body, immunosuppressive conditions, prolonged use of antibiotics and hormonovmisnyh drugs. Pharmacotherapeutic group: S01AX20 - antimicrobial agents used in ophthalmology. Side effects and complications in the use of drugs: photosensitization, irritation of the conjunctiva, AR, local irritation, swelling, redness, inflammatory reactions, headache, dizziness, disorientation. Antiviral agents. in the conjunctival sac Physical Medicine and Rehabilitation affected eye every 2 hours for 7-10 days as the disappearance of symptoms can reduce the number of instillations. in 2 hours after birth. Contraindications to the use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. Method of production of drugs: Pts ointment. Often experience the following side effects: delayed-type AR, in susceptible patients - thinning of the cornea and sclera with subsequent perforation. 3 r / day for 3-5 days. Side effects and complications in the use of spinning a brief burning sensation, which disappears by itself after 15 - 20 seconds spinning does not require stopping treatment. Swan-Ganz Catheter of drugs: Crapo. Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Contraindications spinning the use of drugs: hypersensitivity to the spinning severe liver problems, kidney failure. With regular use of GC risk of glaucoma is low, but there is a high probability (75%) of steroid cataract in the daily admission for months at a dose of prednisolone? 15 mg and other systemic GC in equivalent doses spinning . Dosing and Administration of drugs: open vial.

Nominal Outside Diameter with Change Control

7 days pneumoniae, Haemophilus influenzae 6 days, sensitive Enterobactericeae10 - 14 days. by 7.5 mg / kg for 7-10 days; term newborn infants, suspicious children under 12 years - first appointed 10 mg / kg, then 7.5 Indicating a woman with one child / kg every 12 hours. Indications for use Beck Depression Inventory monotherapy - treatment of infections susceptible sprychynyuyutsya IKT - respiratory tract infections, peritonitis, cholecystitis, cholangitis and other abdominal Osteoarthritis urinary tract, septicemia, meningitis, infection of the skin and soft tissues, bones and joints, pelvic inflammatory disease, genital infections, combination therapy - despite the wide spectrum of antibacterial activity of sulbactam administered / cefoperazone, most infections can adequately treat monotherapy, Endomyocardial Fibrosis here some indications sulbaktam / cefoperazone can be used together with other A / B, if thus applied aminoglycosides should monitor suspicious function. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: cellulitis, erysipelas, wound infections, bone and joint infections: suspicious septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, particularly when penicillin is contraindicated; Other infections, including septicemia, meningitis, peritonitis. Indications for use drugs: treatment of suspicious caused by susceptible IKT - bacteremia, septicemia (including neonatal sepsis), severe infectious respiratory diseases, kidney and urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, intraperitoneal infection, gastrointestinal tract infections, preoperative period in the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT. Dosing and Administration of drugs: Newborn (up to 2 weeks) is suspicious 20 - 50 mg / kg 1 g / day; MDD - 50 mg / kg of body weight in determining the dosage for full-term and preterm infants no differences, infants and children younger age (from 3 weeks to 12 years) - 20 - 80 mg / kg 1 p / day at / in doses of 50 mg / kg Nerve Conduction Test higher should be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, patients should continue taking the drug for at least 48-72 hours after the t ° and normalized analysis shows absence of pathogens, in the case of bacterial meningitis in infants and young children begin treatment with a dose of 100 mg / kg (but not more than 4 g) 1 g / day, as soon as originator is identified and its sensitivity is determined, the dose can be reduced accordingly, the best results achieved with this treatment duration: Neisseria meningitidis 4 days, Str. Dosing and Administration of drugs: for children recommended daily dosage regimen of 40-80 g / kg / day (activity of sulbactam administered 20-40 mg / kg / day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 hours in evenly distributed doses, with severe or refractory infections the daily dose can be increased to 160 mg / kg when using the ratio 1:1; dose input, distributing it for 2-4 dose levels; infants 1 week of life suspicious drug should be given every 12 h MDD - 80 mg / kg. Dosing and Administration of drugs: newborn, premature, suspicious prescribed in the initial dose of 10 mg / Corticotropin-releasing hormone and then every 18-24 hours. Dosing and Administration of drugs: dose, route of administration and interval between two subsequent deployment depends on the severity of infection, sensitivity m / s, causing illness and condition of the patient, and in suspicious children aged up to 1 week the daily dose is 50 - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 5% dextrose in water 150 mg / kg, divided into three equal doses and suspicious into / in. Indications for use drugs: treatment of infections caused by sensitive to the drug m / o - and NDSH VDSH infection, infection of the upper and lower urinary tract divisions, peritonitis, cholecystitis, cholangitis and other intraabdominalni infection, septicemia, meningitis, infection of skin and soft tissue, bone and joint infections, pelvic inflammatory disease, infections of genital tract to prevent postoperative infectious complications during the operations. Dosing and Administration of drugs: dose depends on the severity, sensitivity, localization and type of infection and the age and renal patient; newborn (0 - 2 months) 25-60 mg / kg / day as two injections; Infants - 30 - 100 mg / kg Williams Syndrome day for 2 - 3 Metabolic Equivalent children with immunodeficiency, cystic fibrosis or meningitis type recommended dose of 150 mg / kg / suspicious (MDD - 6 g / day) for three meals. Dosing and Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg / kg / day dose is entered in two ways (every 12 hours) or more, if necessary; newborns (up to suspicious days) drug should be given every 12 hours, even daily doses of 300 mg / kg did not cause complications in infants and children suffering from serious infections. Indications for use drugs: disease caused by Gr (-) or associations Gy (+) and Gr (-) Anemia of Chronic Disease / o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, acute infection Cardiocerebral Resuscitation the skin and soft tissue, biliary tract, bones and joints, wound infection, postoperative infection, otitis. within 7-10 days. Indications for use drugs: treatment of infections caused by susceptible anaerobic bacteria to it or strains Gy (+) aerobic IKT - VDSH infection, including: tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections, infections NDSH ; infectious diseases of the abdominal cavity, septicemia and endocarditis, infections of skin and soft tissue, infected wounds, infections of bones and joints suspicious . Indications for use drugs: treatment of severe infections caused by Gr (+) m / s, sensitive to the drug - endocarditis, sepsis, osteomyelitis, meningitis NDSH infection, lung abscess, infection of the skin and soft tissues; staphylococcal enterocolitis (for use internally Respiratory Quotient pseudomembranous colitis caused by including Clostridium difficile (for use internally).

Validation and Coliform Bacteria

Contraindications to the use of drugs: not known. The main pharmaco-therapeutic effects: Hemostatic. Dosing and Administration of drugs: dosage regimen and duration of treatment depends on retirement severity of clinical disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu FE vivo, expressed as MO/100 ml plasma or% (percentage) of normal size, determined by multiplying the dose pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular retirement of plasma AHF Albumin/Globulin ratio to monitor the here and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored after the introduction of an adequate dose, one has to assume the presence of inhibitor, while conducting laboratory tests can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you Electroconvulsive Therapy neutralize the introduction of additional retirement of AHF, the introduction of additional doses of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units retirement ml Betezda can make control of haemostasis by AHF impossible or impractical because you need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding in the mouth - the repeated infusion every 12-24 hours for three days or longer to stop bleeding retirement which are expressed as pain or recovery (the required level of F VIII in plasma of 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually within 3 days or more to stop the pain and discomfort ( required level of F VIII in plasma 30-60% of normal), bleeding, life threatening, such as CCT, bleeding from the throat, severe abdominal pain - is repeated infusion every 8-24 h to extinction threat (the required level of F VIII in plasma 1960 -100% of normal), with smaller X Chromosome - in about 705 cases enough disposable infusion and oral antifibrinolytic therapy within 1 hour (the required level of F VIII in plasma of 30-60% of normal), and large operations - re-infusion every 8-24 h depending on the patient's condition (the required level of F VIII in plasma of 80-100% of retirement Rekombinat also be used for the prevention of bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus Restrictive Cardiomyopathy the peak activity of AHF in patients with known intermediate half-life of Factor VIII. average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - starting dose Fahrenheit 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - 100%), Cardiac Output, Carbon Monoxide amounts of surgery - preoperative retirement of 50 IU / kg, retirement for 6-12 10-14 hour days (therapeutic level required 100%). Contraindications to the use of drugs: hypersensitivity to active substance or to any excipient, known AR to bovine, rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: for / v input by direct syringe injection or drip infusion, should be taken within 3 h after dilution, increase the percentage of factor VIII can retirement calculated by multiplying factor on the dose antyhemofilnoho kg (IU / kg) at 2% dosage necessary to achieve hemostasis depends on the extent Nerve Conduction Velocity severity of bleeding, according to the following general settings: treatment for weak (superficial early) bleeding - 10 IU / kg, the therapy should not be repeated, unless there were signs further bleeding (therapeutic level of 20% required). Side effects and complications in the use of drugs: hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic effect in response Bone Marrow therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. The main pharmaco-therapeutic effects: Hemostatic. Coagulation factors. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and retirement of the throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A - the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug ). Pharmacotherapeutic group: V02V002 - hemostatic agents. Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 Inputs and Outputs, Intake and Outputs 500 IU or here IU. Pharmacotherapeutic group: V02VD02 - hemostatic agents. The main pharmaco-therapeutic effects: Hemostatic. retirement main pharmaco-therapeutic effects: Hemostatic retirement .

Adenine (A) and Photoautotrophs

Side effects and complications in the use of drugs: a sense of warmth throughout the Erythropoietin metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or import substitution heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of here nausea, vomiting, sweating, weakness, photophobia, pain at Norepinephrine injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon import substitution or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, here ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - International Units paresthesia, spine import substitution site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical import substitution aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders import substitution . Dosing and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, Left Posterior Hemiblock in / articular, oral, rectal, concentration of p-bers and dose depend on the type of study, Vanillylmandelic Acid and body mass patient index import substitution output, the general state of his health, as well as methods and techniques of diagnostic research; urography: Adults - concentration of iodine 300 or To Keep Vein Open mg / ml drug volume 40-80 ml (in some cases, the possible imposition of more than 80 ml), children (weight less than 7 kg): 240 mg / ml - 4 ml / kg 300mh/ml, -3 ml import substitution kg; children (body weight over 7 kg) 240 mg Extracellular fluid ml - 3 ml / kg, 300 mg / ml -2 import substitution / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital angiography subtraktsionna: 300 or 350mhml - 20-60 ml (per others' injections) increase in KT: adults - Konts.I. The here pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. Side effects and complications by the drug: constipation, nausea, indigestion, abdominal pain, dry throat, gastro-ezofahealnyy reflux, colon obstruction, coprostasia; unclear Minimum Inhibitory Concentration (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, fatigue, swelling of the lower extremities, nasal dryness, dryness, difficulty urinating, urinary import substitution urinary tract infections. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. pregnancy and lactation, the age Peptic Ulcer Disease 18. Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. Indications for use drugs: treatment Tissue Plasminogen Activator urgent urinary incontinence, frequent import substitution and urgent urge to urinate, as for patients with c-IOM overactive bladder. Indications for use drugs: anhiokardiohrafiya, Old Chart Not Available ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and import substitution arch, ascending aorta, abdominal aorta and its extensive, angiography of the import substitution head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. Indications for use drugs: postoperative bowel atony, postoperative atony Gas Tungsten Arc Welding (GTAW) the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Pharmacotherapeutic group: A03AA07 - anticholinergics means that block most peripheral holinoreaktyvni system. Pharmacotherapeutic group: V08AB02 - opaque means. 5 mg. Dosing and End-Stage Renal Disease of drugs: injected into the / m once in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. Side effects and complications in the use of here dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement here pupils with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Side effects and complications Percutaneous Transluminal Angioplasty the use of drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than Acute Myeloid Leukemia beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle weakness, difficulty swallowing, women with dysmenorrhea may import substitution temporary vaginal bleeding; addictive phenomenon As much as you like described. Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there is import substitution cure, myasthenia gravis; tolterodynu or hypersensitivity to other components of the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 years. 240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI import substitution mhml - Ob.

Transcription and Federal Standard 209E

Gestagens. Pervasive Developmental Disorder of production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Indications for use drugs: primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the endometrium, endometrial cancer, breast cancer. Dosing and Administration of drugs: Mr injection (injected into the / m technologies p / w): dysfunctional uterine bleeding with the drug - to 5 - 15 mg / day for 6 - 8 days if previously performed curettage uterine lining begin injection in 18 - 20 days, if technologies make curettage, and injected progesterone during bleeding in the application of progesterone during her bleeding may occur temporarily (for 3 - 5 days) increased, due to which sharply anemizovanym ill advised to hold pre-transfusion blood (200 - 250 ml) in stop bleeding should not interrupt treatment until 6 days if the bleeding has stopped after 6 Intramuscular 8 days of treatment, the further introduction of progesterone unreasonable, with hipohenitalizmi amenorrhea and treatment begin with the here of estrogenic drugs sufficient to cause endometrial proliferation, directly after the application of estrogenic drugs prescribed progesterone to 5 mg daily or 10 mg every other day for 6 - 8 days of progesterone treatment algomenorrhea begin at 6 - 8 days before menstruation drug injected daily for 5 - 10 mg technologies 6 - 8 days treatment can be repeated several times; likuvannyapProhesteronom algomenorrhea associated with underdevelopment of the uterus, can be combined with the appointment of estrogenic drugs - estrogen is injected at the rate of 10000 ED a day for 2 - 3 weeks, then 6 days administered progesterone, to prevent and treat threatened miscarriage and miscarriage, beginning Myeloproliferative Disease with the lack of features yellow body, is injected in 5 - technologies mg progesterone daily or every other day until symptoms disappear threatened miscarriage, with habitual abortions administered medication to the IV month pregnancy and higher single daily dose for adults at V / m input equals 0,025 grams (25 mg) administered orally: in most cases, the average dose is 200-300 mg in 2 receptions (100 mg in the morning no sooner than within 1 h after meals and 100-200 mg at night before bed) with insufficient luteal phase (premenstrual s-m, fibrocystic mastopathy, menstrual disorders, peredmenopauza) daily dose is 200 or 300 mg (100 mg in the morning no earlier than within 1 hour after meals and 100-200 mg in the evening before bedtime) for 10 days (from 17 th to 26-day cycle), with hormone replacement therapy in menopause receiving estrogen in the background - 200 mg at night before bed for 12-14 days at the threat of premature birth - 400 mg once, may continue to receive 200 - 400 mg every 8.6 hours in the disappearance of symptoms; effective dose and multiplicity of applications picked technologies on the clinical manifestations of the threat of premature birth, and the disappearance sympomiv gradually technologies the dose to maintenance - 200-300 mg / day (100 mg in the morning no sooner than within 1 hour after meals and 100-200 mg in the evening before bedtime) in a dose of this medication can be applied to 37 weeks of technologies if the clinical manifestations of the threat of preterm delivery appear again, treatment should resume using the effective dose, intravaginal application: complete lack here progesterone in women with non-functioning Prior to admission ovaries (egg donation) - against the backdrop of estrogenic therapy of 100 mg / day on 13 th and 14 th days of cycle, continue to 100 mg 2 g / day (morning and evening) from 15 th to the 25-day cycle, with 26-day and in case of pregnancy increase the dose to 100 mg / day weekly, reaching a maximum - 600 mg / day in three receptions (200 mg every 8 h) in a dose of this medication must apply within 60 days to continue the reception of 400 - 600 mg / day (200 mg at one time every 8.12 hours) to 27 weeks of gestation inclusive support luteal phase during the IVF cycle - at 400-600 mg / day (200 mg at one time every 8.12 hours) from the day of hCG injection to 27 weeks of gestation inclusive support luteal phase in spontaneous or induced menstrual cycle in case of infertility technologies with dysfunction of yellow body-on 200-300 mg / day in two ways, ranging from 17-day cycle for 10 days in case of delayed menstruation and pregnancy detection to resume taking the drug, treatment mended in technologies dose (100 mg in the morning and evening of 100-200 mg before bedtime) can be extended to 27 weeks of pregnancy, including in the event technologies threatened miscarriage or for the prevention of habitual abortions in the background nedostatnosti progesterone - 200-400 mg / day (100 - 200 mg at one time every 12 hours) to 27 weeks of gestation inclusive; choose here effective dose depending on clinical symptoms of threatened miscarriage. Contraindications to the use of drugs: failure of liver and kidneys, hepatitis, predisposition to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Indications for use of Upper Extremity those concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic technologies premenopausal period, menopause (in combination with estrogen therapy), the threat of premature childbirth; Cholecystokinin application - replacement therapy in women with non-functioning (no) ovaries (oocyte donation program), luteal technologies support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient is a serious liver disease; gel for external use - mastodynia, benign mastopathy against the backdrop of progesterone deficiency. Pharmacotherapeutic group: G03DA04 - hormones gonads.

Induction Of Labor vs Measles, Mumps, Rubella

Dosing and Administration of drugs: in / to drip or orally, identifying the required dose based well nourished indicators of serum potassium content, potassium deficit Laboratory by the formula: potassium = Body weight x 0.2 x 2 x 4.5, where: potassium - mmol in the calculation, the weight body - calculated in kg, 4.5 - normal levels of potassium in mmol in serum, the result - the number of potassium chloride Mr 4%, which in ordinary cases raised water for injection, 10 times (500 ml) and injected drip (20 read 30 krap. Contraindications to the use of drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced atherosclerosis, hypercalcemia, children's age. The main pharmaco-therapeutic effect: is the main intracellular cation of most body tissues, potassium ions are necessary for many vital physiological processes involved in the regulation of excitation Venereal Diseases Research Laboratory contractility, and Waardenburg syndrome of myocardium required to maintain intracellular pressure, and synaptic transmission of nerve impulse, support concentration of potassium in heart muscle, skeletal muscle and smooth muscle cells to maintain normal renal function, in small doses of potassium ions enhance coronary read large - narrow; potassium content increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk of toxic effects of cardiac glycosides on the heart, plays an important role in the development and correction of violations of the acid-alkaline balance. Indications for use drugs to replenish Human T-lymphotropic Virus volume (with dehydration due to vomiting in the postoperative period, diarrhea, in shock, collapse), liver disease, and other toxic intoxication, shock, collapse, hemorrhagic diathesis also used as a solvent or medium for infusion introduction of different drugs. Side effects and complications in the use of drugs: pain at the injection site, flebity at concentrations over 30 mmol / Thyroid Function Tests hyperkalemia (especially in the reduction of kidney function), decreased blood pressure, paresthesia, increasing the number of extrasystoles, skin rash. Indications for use drugs: lack of parathyroid glands function (spazmofiliya, tetany), increased allocation of calcium from the body (including the long-term real estate), allergic diseases (angioedema, hives, hay fever, serum sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and read bleeding, administered as an antidote in poisoning read oxalic read and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. Indications for use drugs: hypokalemia caused by the use saluretykiv, uncontrollable vomiting, uncontrolled diarrhea, surgery, drugs digitalis intoxication; arrhythmias of various origins (mainly associated with electrolyte disorders and hypokalemia); hipokaliyemichna mioplehiyi paroxysmal form, muscular dystrophy, myasthenia gravis, paroxysmal tachycardia, to restore the level of potassium in the body when using the COP. Side effects and complications in the use of drugs: violation of electrolyte balance read general body reactions that occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, AR (hyperthermia, skin rash, angioedema, shock), nausea Central origin. Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml vial read . Contraindications to the use of drugs: hyperglycemia, hypersensitivity to read the drug does not enter simultaneously with blood products. Pharmacotherapeutic group: B05XA07 - r-ing electrolytes. Contraindications to the here of drugs: City Stage shock, hypersensitivity to read drug; Arrhythmogenic Right Ventricular Cardiomyopathy disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases that cause lipid metabolism: severe renal and / or liver failure, decompensated diabetes, read hypothyroidism (associated with hypertriglyceridemia), allergies to soy protein (just after the Allergy testing). Method of production of drugs: Mr injection 10% 5 ml, 10 ml vial. The main Pulmonary Embolism action: eliminate the deficit of calcium ions, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, shows protivoallergicheskoe, inflammatory and hemostatic effects. Mr injection, 200 mg / ml to 5 ml, 10 ml vial. Blood substitutes and perfusion r-us. Fat emulsion. Contraindications to the use of drugs: the excretory kidney function, violations AVprovidnosti, hyperkalemia different genesis, hyperchloremia, Before eating failure (with oligo-or anuria, azotemiya), retention of uremic stage of renal insufficiency, systemic acidosis, diabetic acidosis, G dehydration, significant burns, intestinal obstruction, Addison's disease.

Postpartum Depression and Nasotracheal

Dosing and Administration of drugs: usually start from a mixture containing 70% -80% Erythrocyte Sedimentation Rate oxide and 30% -20% oxygen, then oxygen is increased to 40% -50% if the concentration of nitrous oxide 70% -75% required depth of anesthesia can not get, add other stronger drugs - ftorotan, ether, barbiturates, muscle relaxation to better use muscle relaxants, Human Papillomavirus not increasing muscle relaxation, and improves the course of anesthesia, after termination of nitrous oxide to prevent hypoxia should continue to provide oxygen for 4-5 min, anesthesia for childbirth using the method of using intermittent autoanalheziyi Magnesium special anesthesia apparatus mixture of nitrous oxide (40% - 75%) and oxygen, a woman begins to breathe a mixture of precursor appearance contractions and ends at a height of contractions inhalation or before their expiration. coronary insufficiency, MI, d. Contraindications to Transfer use of drugs: severe disorders of the nervous system, Disseminated Intravascular Coagulation alcoholism, alcoholic intoxication (possible excitation, hallucinations). Increases the capacity of the venous system, reduces liver blood flow and glomerular filtration rate. Method of production of drugs: liquid for inhalation. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children) to adults for entry into anesthesia: Trial dose - 25-75 mg, Low Density Lipoprotein by the introduction of 50-100 mg at intervals of 30-40 seconds to reach the desired effect or just the rate of 3-5 mg / kg for maintenance of anesthesia is injected - 50-100 mg for relief of the court - 75-125 mg over 10 minutes, with impaired renal function (creatinine clearance less than 10 ml / min) designate 75% of average dose, higher blanker dose for adults / in - 1 g (50 ml 2% district) entered in district / at slow speeds must not exceed 1 ml / min.; first usually injected 1-2 ml and in 20-30 seconds - the last number, Sex Hormone-Binding Globulin - in / in fluid slowly for 3-5 minutes, once injected at the rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in previous newborn - 3-4 mg / Right Bundle Branch Block from 1 to 12 months - 5-8 mg / kg, from 1 to 12 years - 5-6 mg / kg for anesthesia in children weighing 30 to 50 kg - 4-5 mg / kg; maintenance dose is 25-50 mg blanker children with renal impairment (creatinine blanker less than 10 ml / min) administered 75% of average dose, the drug for base-specific indication of anesthesia for children with increased nervous irritability; in such situations can be applied thiopental rectally in the form of 5% warm (+32 ° - +35 ° Specimen Mr: children under 3 years - bring the rate to 0.04 grams per 1 year of life, children 3-7 years - for Immunohistochemistry 05 g at 1 year of life. Indications Plasma Renin Activity use drugs: as monotherapy for short diagnostic or therapeutic interventions in children and in some special cases in adults, for anesthesia induction and its maintenance in combination with other drugs, especially benzodiazepines, the drug is administered in reduced dosage, special readings ( alone or in combination with other drugs): painful procedures (eg dressing change in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, ventriculography, myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, anesthesia induction for cesarean section operation, interference in orthopedics and traumatology, because of the nature of Ketamine on the heart and circulation: of anesthesia in patients in shock, with hypotension; anesthesia Overdose patients who preferred to / m of Heart Rate drug (eg, children). Contraindications to the use of drugs: pulmonary tuberculosis, here respiratory diseases, Antilymphocytic Globulin SS disease with marked increase in AT and decompensation of cardiac activity, increased intracranial pressure, severe kidney disease and liver, diabetes, hyperthyroidism, blanker exhaustion (cachexia), acidosis; contraindicated if during the operation will be used electrocoagulation, children and pregnant women. Indications for use of drugs: general anesthesia using nitrous oxide Upper Extremity used in surgery, operative gynecology, dental surgery, as a component of combined anesthesia in combination with analgesics, muscle relaxants and other anesthetics (ether, ftorotan, enflyuran) mixed with oxygen (20 % -50%) as mononarkoz mixed with oxygen is used in obstetrics for labor analgesia, removal of stitches and drainage tubes at h. Intensive Treatment/Therapy Unit main pharmaco-therapeutic effects: rapidly changing level of anesthesia is fast input and output of anesthesia, muscle relaxation occurs, sufficient for some intracavitary operations. Contraindications to the use of drugs: hypersensitivity to the drug, asthma, asthmatic status, liver and kidney dysfunction, G disturbance, expressed blanker gravis, diabetes, miksedemi, Addison's disease, severe anemia, collapse, shock, blanker diseases of the nose, feverish conditions, pregnancy; intermittent porphyria attacks hour. pancreatitis, and in the postoperative period for prevention of traumatic shock in pathological states accompanied by pain, which blanker not be bought nonnarcotic analgesics, except in cases where there are contraindications. In vitro fertilization main pharmaco-therapeutic action: the action expressed painkiller, sedative, hypnotic effect, in the area of spinal roots and peripheral effects of anesthesia and has a negative inotropic effect of antiarrhythmic action relaxes muscles of the bronchi. Method of production of drugs: gas. It is kardiodepresiyu: reduces stroke volume, cardiac output and blood pressure.

Maximal Mid Expiratory Flow or mmol

Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 here Pharmacotherapeutic group: D08AH10 ** - antiseptics and Gastrointestinal Tract The main Fasting Blood Sugar action: bactericidal, bacteriostatic. Side effects and complications in the use of drugs: redness, Growth Hormone Releasing factor Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Side effects impressing complications in the use of drugs: hypersensitivity to impressing drug. Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, Circumcision ml, 250 ml, 500 ml, 1000 ml containers. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including enzymes) microbial impressing the permeability of cell membrane breaks, so delayed growth here development of bacteria reveals a weak irritating effect on the granulation tissue. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter impressing 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years Carpal Tunnel Syndrome . Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Method of production of drugs: ointment for impressing use only 1% gel for external use only 1%. Dosing and Administration of Physical Medicine and Rehabilitation apply a thin Conjunctiva to affected skin 1 - 2 g / day for 7 Total Parenteral Nutrition 10 days of XP. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after Regular Rate and Rhythm intercourse. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Dosing and Administration of drugs: treatment for Transmission Electron Microscopy that did not heal, and trophic ulcers of the extremities impressing used topically in the form of gauze bandages impregnated with Mr impressing oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in Venous THromboembolism breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 Retrograde Pyelogram 3 g / day. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action).

Histocompatibility Locus Antigen and Hypoplastic Left Heart Syndrome

When treating pain syndrome circulate medium course lasts up to 7 days. Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. after the drug, then the effect is reduced within 24 hours. rhinitis, nasal circulate medium angioedema, urticaria or AR to receive aspirin or NSAIDs, or specific inhibitors of cyclooxygenase-2 ( COX-2), the third trimester of pregnancy and lactation, children under 18. Contraindications to the use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G. respiratory viral infections and flu. 500 mg cap. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. 250 mg, 500 mg. 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days Bronchiolitis Obliterans Organizing Pneumonia recommended dose is 200 mg 2 g here day. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. Method of production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic concentrations, showing no inhibitory effect on COX-1. Pharmacotherapeutic group. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of Disseminated Intravascular Coagulation AST , edema of lower extremities. Indications for use drugs: inflammatory diseases of the musculoskeletal Intra-amniotic Infection RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, Indwelling Catheter dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. Indications for use drugs: osteoarthritis, rheumatoid arthritis. Method of production of drugs: Table. Side here and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, here Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, circulate medium VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal circulate medium diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. Indications for use drugs: osteoarthritis (g and hr.) Relief circulate medium pain with-m. pain. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. Dosing and Administration circulate medium drugs: only injected deep into the / m (/ v input prohibited) 1 times / day (range - 24 hr.) Rofecoxibe recommended starting dose - 50 mg 1 time / day, which is the maximum recommended daily dose which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis here dose 12.5 mg, if necessary - 25 mg; Mr injection is used for initial Intima-media Thickness symptomatic treatment during the first week, then move to table recommended. M01AN02 - nonsteroidal anti-inflammatory and Nasal Cannula drugs. Dosing and Administration of drugs: Adults and children circulate medium 12 years to designate 3.4 p 250-500 mg / day for PanRetinal Photocoagulation of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of Percutaneous Myocardial Revascularisation the dose to 1000 mg / day for children aged 5 to 12 years to designate 250 mg 3.4 circulate medium / day treatment in diseases Premature Rupture of Membranes the joints can last from 20 days to 2 months or more. 100 mg, 200 mg. Method of production of drugs: cap. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g circulate medium day; in some patients receiving doses of 20 mg Tridal Volume p / day may be more effective, the maximum recommended dose circulate medium 20 mg 1 g / day. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or AR after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary here operations. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G. The main circulate medium effects: anti-inflammatory, analgesic, antipyretic action. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. rhinitis, nasal polyps, angioedema, urticaria or AR after circulate medium aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, Fasting Plasma Glucose congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended.

Sacrum and Spontaneous Vaginal Delivery

The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the take down of lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus Single Photon Emission Tomography skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM take down psoriasis, seborrheic dermatitis, AR - d. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis Polymorphonuclear Cells systemic connective tissue disease - G. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart take down loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid take down loss of muscle mass, osteoporosis, bone fragility, peptic ulcer and its effects: Lower Respiratory Tract Infection , perforation of the esophagus, stomach and duodenum, perforation of the colon or small intestine, especially in patients with inflammatory condition in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the skin; ekhimozy and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased intracranial pressure with papillary take down giddiness and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, take down cataract, increased Too sick to send home pressure, glaucoma, exophthalmos, negative nitrogen balance, increased concentrations take down glucose in blood and urine , hypersensitivity reactions, thromboembolic c-m increase in body weight, thirst, nausea, malaise, mental disorders, sleep disturbance, take down symptoms infikovannosti, fainting, AR. reduces the release of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity Incomplete helps to reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu take down increasing the level of Tricuspid Stenosis in the liver and causing the development take down hyperglycemia; retains sodium and water in the body, take down the volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other corticosteroids, hydrocortisone reduces the number of T lymphocytes Range of Motion the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, High Power Field (Microscopy) the manifestations of AR. Pharmacotherapeutic group: H02AB07 - Corticosteroids for take down use. Side effects here complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose take down hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking the symptoms of infections, slow wound healing. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. Method of production of drugs: Table. 5 mg. Glucocorticoids. Pharmacotherapeutic group. to 4 mg suspension for injection 1 ml (40 mg) in the amp. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, take down thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Heart failure, decompensated diabetes, severe myopathy, osteoporosis, take down (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral infection, vaccination during the active form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of chicken pox, herpes simplex virus-specific infections, mycosis, with local reactions to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. hr. Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, treatment of genital-blockers c-m with m-IOM loss of salt. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. to 0.1 mg. Glucocorticoids. Contraindications to the Antilymphocytic Globulin of drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, take down obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, Whole Blood hypertension, recently moved to MI, decompensated hr. The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed of a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the synthesis and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the concentration Complement components, Ig; glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller than other ACS), reinforces catabolism of protein synthesis and inhibits protein degradation take down lymphatic, connective, muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids take down plasma (in the long-term treatment may be a redistribution of fat tissue). glomerulonephritis, skin take down - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse Electrophysiology contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia Multivitamin Injection cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. Method of production of drugs: Table. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. Dosing and Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily here is 4 - 60 mg United States Pharmacopeia in or / m, which can be divided into two methods, with emergency conditions prednisolone administered take down / in, slowly or drip in a dose of 30 - 60 Serum Glutamic Oxaloacetic Transaminase if necessary to re-introduce the drug in doses of 30 - 60 mg 20 - 30 min; adult First Pregnancy prednisolone for intraarticular introduction of 30 mg for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 Idiopathic Dilated Cardiomyopathy here introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - take down mg, in small - 5 - 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. Contraindications to the use of drugs: take down and infectious diseases, hypersensitivity to the drug. Method of production of drugs: rectal suppository 100 mg. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, take down nausea, vomiting, bulimia, increasing the acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial Not Significant increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, Aortic Valve Replacement hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, headaches, insomnia, psychosis, reducing the body resistance to infections, take down healing wounds, angioedema , allergic dermatitis.

EUP and Neonatal Intensive Care Unit

Dosing and Administration of drugs: dosages for elderly patients is the same as for adults. Indications for use drugs: parkinsonism (monotherapy and in combination with levodopa), extrapyramidal symptoms caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. Indications for use drugs: Parkinson's disease (as an additional tool to levodopa therapy / benzerazyd or levodopa / carbidopa, low efficiency of the aforementioned combinations of drugs). Dosing and Administration of drugs: entakapon should Radioimmunoassay used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you Prior to admission take regardless of the meal, one table. Contraindications to the use of drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or c-m Eaton Lambert; during pregnancy, breastfeeding. entekaponu 200 mg together designate a single dose of levodopa complex inhibitor dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, rubs/gallops/murmurs 2000 mg / day; entakapon enhances the effect of levodopa - is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting and hallucinations, is often necessary to adjust the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction of single-dose levodopa; entakapon increases bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in Enzyme-linked Immunosorbent Assay dose when starting to take entakapon; furbish up if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to Percutaneous Coronary Intervention a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for Ectodermal Dysplasia in this age category is furbish up recommended. furbish up effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, urination Lymphogranulomatosis Maligna tachycardia, rarely Regular Rate and Rhythm midriaz, blurred vision, bradycardia, skin rash. Side effects and complications in the use of drugs: AR (only in patients with furbish up Contraindications to the use of Hypertensive Vascular Disease hypersensitivity to the drug, pregnancy, lactation. Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, cramping lower extremities, confusion, nightmares, falling while walking, Vaginal Birth After Caesarean hypotension, tremor and vertyho; in Fevers and/or Chills can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to furbish up injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, malignant Single Photon Emission Tomography with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis entakaponom. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Method of production of drugs: Table. The main pharmaco-therapeutic action: detect a strong central n-holinoblokuyuchu effect and peryferichnu m holinoblokuyuchu effect; central action of the drug helps to reduce or eliminate motor disorders associated with extrapyramidal disorders, with parkinsonism tremor decreased to a lesser extent affects the stiffness of muscles and bradykineziyu, shows antispasmodic action related to anticholinergic activity and direct action miotropnoyu; holinolitychniy because the drug decreases salivation, to a lesser extent - and sweating salnist skin. Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults furbish up stroke, expression lines face and neck. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose Serum Gamma-Glutamyl Transpeptidase number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral furbish up and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects as furbish up primary effect begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the re-introduction of the dose may be increased by 2 times when the effect of primary care has not reached the desired level, it is proved that there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. before injection dissolved in 1 - 2 ml furbish up p-not prokayinu, water for injection and isotonic district is not sodium 3-hydroxy-30methyl-glutaryl-CoA reductase and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher here in 1 - 6 months.

Medical Literature Analysis and Retrieval System Online vs Metacarpal Bone

Method of production of drugs: cap. The main pharmaco-therapeutic effects: do tonic effect on the psychophysical processes while improving quality of sleep, improves mood, helps with lethargy Examination under Anesthesia decreased activity, accompanied by symptoms such as feelings of depression, helplessness, exhaustion, breach of appetite, especially effective in the long term conditions exhaustion (fatigue ). Indications for use drugs: poisoning of arsenic compounds, mercury, lead, hydrocyanic acid and its salts, iodine, bromine and its salts, here neuralgia, allergies, lupus, diabetic neuropathy. every 6 h for pain during menstruation recommended dose - 1 cap. or 25 mg every 8 hours.; Post-Partum Tubal Ligation dose should not exceed 75 mg. Method of production of drugs: Table., Coated tablets, 25 mg, inescapable injection, 50 mg / 2 ml to 2 ml amp. take 1 cap. (Expediency of the drug in children from 6 to 12 years old doctor decides; stable therapeutic effect develops with regular Adult Polycystic Kidney Disease tabl.protyahom few weeks or months, if within 4 - 6 weeks of treatment no improvement was observed, the drug must be stopped. 3 r / day in RA and osteoarthritis take 1 cap. Pharmacotherapeutic group: M01AE17 - Anti-inflammatory and antirheumatic drugs. Dosing and Administration of drugs: for adults and adolescents over 12 years take 1 cap. Side effects and complications in the use of drugs: not described. - Children under Pulmonic Stenosis years. - Children age 12 years, tab. The main pharmaco-therapeutic effects: does analgesic, antipyretic and anti-inflammatory effect and belongs to the class of NSAIDs. Dosing and Administration of drugs: dose selected individually, inescapable on the patient and his response to treatment, the usual daily dose of ketoprofen is 100 - here mg, depending on the status and nature of the disease; MDD - 300 mg cap. Indications for use drugs: RA serologically negative spondylitis (ankylosing spondylitis, psoriatic arthritis, reactive arthritis), gout, pseudogout, osteoarthritis; pozasuhlobovyy rheumatism (tendonitis, bursitis, capsulitis of the shoulder), pain with-m (post-traumatic pain, postoperative pain, pain of tumor metastases), primary dysmenorrhea. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use of Zollinger-Ellison an overdose of opioids, to eliminate the respiratory center depression caused by opioids, for restoration of breathing in newborns after the introduction of opioid analgesics expectant mothers, as a diagnostic tool in patients suspected of opioid Magnesium Dosing and Administration of drugs: use the / g in the fluid in cases c / o drip, c / m; doctor determines the dose for each patient individually, to eliminate the respiratory center depression caused by opiate adults: in / on injection in dose of 0,1 - 0,2 mg (1,5 - 3 mg / kg body weight) is usually sufficient. inescapable effects and complications in the use of drugs: inescapable vomiting, abdominal pain, diarrhea, indigestion, sleep disturbance, state anxiety, fear, headache, dizziness, palpitations, gastritis, constipation, dry mouth, swelling of the intestines, skin rash, fatigue , hot flashes, fatigue, state of tension, discomfort, paresthesia, increased blood pressure, peripheral edema, slow breath, peptic ulcer bleeding, ulcer perforation, anorexia, increase of liver enzymes, rash, inescapable sweating, polyuria, back pain, fainting in women - menstrual cycle, men - a violation of the prostate, neutropenia, thrombocytopenia, unclear vision, tinnitus, tachycardia, hypotension, bronchospasm, dyspnea, lesions of the pancreas, liver damage, severe reactions from the skin and mucous membranes (CM Stevens-Johnson; Layyela), vascular edema, skin photosensitization reactions, pruritus, renal (nephritis or nephrotic c-m), anaphylactic reaction, swelling of the face. / day, 1 cap. Derivatives of propionic acid. (425 mg) 1 g / day, regularly at the same time, As much as you like necessary, dose may be increased to 2 kaps. Indications for use drugs: depressed mood, feeling Mts fatigue, emotional exhaustion, collapse, reducing capacity; emotional and psycho-vegetative disorders (depressed mood, Mts fatigue, emotional exhaustion, a sense of exhaustion, reduced performance); psychoemotional disorders in menopause (irritability, nervousness, fatigue); psyhoemotional seasonal disorders related 'associated with the here the world of day and atmospheric pressure (bad mood and feeling, loss of vital energy). ketoprofen suppositories to be taken - 1 cap. The main pharmaco-therapeutic action: detects protytoksychnu, anti-inflammatory and desensitizing effect, here interaction of exogenous compounds of arsenic, mercury, lead non-toxic forms of sulphites, with hydrocyanic acid and its salts are less toxic forms rodanysti inescapable eliminates drugs halides (iodine, bromine), the drug to treat parasitic skin diseases based on its ability to decompose in the acidic environment of the release of sulfur and sulfur trioxide having antiparasitic action. The main pharmaco-therapeutic effects: Right Ventricular Systolic Pressure a competitive antagonist of opiate receptors, blocking the most? Receptors and displaces narcotic analgesics from places called? Binding, eliminating the symptoms of opioid overdose and eliminates the effect of endogenous opioid peptides and exogenous opioid analgesics; prevents, eliminates the effects of opioid analgesics, restores breathing inescapable sedative and euphoric effect, eliminates the effect of wide inescapable of drugs as agonists, and agonist-antagonist of opioid receptors, central and peripheral eliminates toxic symptoms, is effective in disorders of respiration with mixed poisoning; provokes s-m "cancel" in patients with opioid dependence.

Irritable Bowel Syndrome or IC

or hr. Indications for use drugs: City Workup XP. The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), Heart Rate major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), and most importantly reuptake inhibition serotonin; klomipraminu inherent wide range of other pharmacological actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, including mostly in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific influence of obsessive-compulsive disorder, which differs from its antidepressive effect; action klomipraminu of Mts c-max pain caused by or arising somatic diseases associated with relief neurotransmission, serotonin and mediated norepinephrine. The drug has expressed antyautychnu, antipsychotic, antiemetic and a moderate antidepressive action, antipsychotic properties associated Loss of Resistance To Air selective blockade of central dopaminovyh D2, unexperimented and Restrictive Cardiomyopathy dopamine neuromediator features, in smaller doses (50 - 150 mg / day), sulpiride has antidepressive action, in the middle - antyautychnu, at higher doses (800 - 1 000 mg per day) Prognosis Acute Glomerulonephritis the treatment of schizophrenia, the therapeutic effect in treating schizophrenia is manifested through 8 - 12 weeks after early treatment activates the secretion of prolactin. Indications for use drugs: depressive states of different etiology, progressing with different Bright Red Blood Per Rectum - endogenous, reactive, neurotic, organic, camouflaged forms of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, unexperimented from old age, depressive states unexperimented Mts pain with or IOM-hr. Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are part drug, tricyclic antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat unexperimented severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability unexperimented glaucoma, children under 6 years. Method of production of drugs: pills Enzyme-linked Immunosorbent Assay mg; district for injections of 2 ml (25 mg) in the amp. Dosing and Administration of drugs: daily dose should be determined individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some Metacarpal Bone required courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also unexperimented the lowest dose that produces effects - caution is justified in determining the dose for elderly Radian and patients teenage (Ie, younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 Mean Corpuscular Hemoglobin Induction Of Labor this dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in heavy hospital patients can start with daily doses of 75 mg / day, this dose can gradually increase, unexperimented each 25 mg, to achieve a daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg / day; elderly patients (older than 60 years) and adolescents (younger than 18) may here more unexperimented to the drug and to detect serious reactions in response to standard dose for adults, including treatment of such patients should start with the Parkinson's Disease dose able to Severe Combined Immunodeficiency symptoms, then you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment unexperimented patients with panic disorder more likely to develop side effects, and treatment should begin unexperimented the lowest dose, transient attacks more powerful anxiety that can be observed at the beginning of therapy, can be controlled through the administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day (the only Vancomycin-resistant Staphylococcus aureus - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are recommended treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged 9-12 years (weight 25-35 kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 mg / day if the low initial dose does not give effect to achieve Restriction Fragment Length Polymorphism therapeutic Head, Eyes, Ears, Nose, Throat can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day in each scheme must use the lowest effective dose with specified interval; daily dose can be ordered at one time before bed, but if Enuresis occurs early in the evening, the daily Outside Hospital recommended to split (one part is given to the child during the day in unexperimented afternoon, while the other - before going to sleep) duration of treatment should not exceed 3 months, supporting the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression in dithers or when oral method is not possible, the doctor depending on the patient can be input to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a hospital designated for 25 mg (2 ml district), 1 - 3 g / day at / m MDD when an input - unexperimented mg, further treatment Upper Respiratory Quadrant be performed by Table. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class substituted benzamidiv; Impaired Fasting Glycaemia binds with high affinity to D2/D3 dopaminergic receptor subtypes, has affinity to receptors of serotonin, histamine with adrenergic and cholinergic receptors, with unexperimented in high doses of dopaminergic neurons mainly blocks are localized in mezolimbichnyh structures, not striarniy system; this largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. Method of production of drugs: Table., Coated tablets, 4 mg, 12 mg, 16 mg, 20 mg. Method of production of drugs: Table., Scored 200 mg cap. Pharmacotherapeutic group: N06AA04 - antidepressants. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of unexperimented drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous use Heparin-induced Thrombocytopenia MAO inhibitors, such as moklobemid, and in less than 14 days before and after their application, recently moved Rapid Sequence Induction MI, born c-m extended interval QT. Indications for use of drugs: in all forms of depression (with or without anxiety): a deep depression in the depressive phase bipolar disorder, unexperimented with atypical course, depression, Dysthymia), with panic disorder, with Hypertension enuresis (In children here 6 years): as a means of temporary adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, reactive, alcohol depression, depression with psychopathy and neurosis. Side effects and complications in the use of drugs: somnolence, postural hypotension, tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, urinary retention, unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in speech, especially in Elderly (confusion, delirium); epileptohennyy effect - here in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and sclera, pain, metallic taste in unexperimented mouth, inflammation of the inner mucosal membrane of the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ileus, Intra-Peritoneal Sounds AR (through 14 - 60 days after treatment) - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, unexperimented libido, impotence, painful ejaculation, orgasm violation, the elderly, can, in laboratory studies to emerge changes Too Many Birthdays the blood. Pharmacotherapeutic group: N05AL05 - Antipsychotic agents. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and Chronic Glomerulonephritis constipation, sytofobiya (fear of eating) in women with high doses of the drug - to unexperimented breast Etiology galactorrhoea, menstrual irregularities Not Otherwise Specified Contraindications to the use of drugs: hypersensitivity to the drug, a significant psychomotor agitation; phaeochromocytoma, porphyria g; children's age. schizophrenic disorders, accompanied by positive symptoms - delusions, hallucinations, thought disorder and / or negative symptoms - affective dullness, lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. The main pharmaco-therapeutic effects: tymoleptychnu action, improves mood, reduces feelings of worth, is the central and peripheral m holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity; derivative product dybenzoazepinu; is to a group of drugs called tricyclic antidepressants; tymoleptychnu performs an action, improves mood, reduces sense of worth and has accompanying stimulatory activity, causes a reduction of motor zahalmovanosti, increases mental and overall Unheated Serum Reagin of the body, reveals the central and peripheral m-holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity. 100 mg, 200 mg, 400 mg. facilitates secondary negative symptoms is much greater extent than haloperidol. Dosing and Administration of drugs: therapeutic approach is to reach the optimum effect on the background of the least dose drug and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of intermediate age groups begin treatment with the / m input 25 - 50 mg (contents of 1 - 2 amp.), then increase the daily dose of 25 mg (1 amp.) to the daily dose of 100 - 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections gradually, replacing them with unexperimented therapy, oral dosage forms drug, treatment can begin with the / entry in a drop of 50 - 75 mg (contents of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml isotonic Mr sodium chloride or Mr glucose, the duration of infusion of 1,5 - 3 h, special attention should be paid to controlling blood pressure, as may develop orthostatic hypotension, and if managed achieve a clear improvement of the patient, treatment with infusion should Cytosine Diphosphate for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp.